ACE and cancer: Consequently, well-established RAAS inhibitors (RAASi), including angiotensin-converting enzyme (ACE) inhibitors (ACEIs), angiotensin receptor blockers (ARBs commonly referred to as sartans) and beta-blockers (BBs) have been suggested as potential supplementary therapies for cancer and/or agents for CVT prevention [7].